ArticleAnnals of medicine and surgery (2012)2026

A new era in chronic spontaneous urticaria: FDA approval of the oral BTK inhibitor remibrutinib.

Mahnoor Jan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.